OpenLegislation

Division 2 CASE DEFINITIONS OF COMMUNICABLE DISEASESF1

United Kingdom Repealed

Original text. Later amendments are not shown.

  1. 2.1ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) AND HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION
  2. 2.2ANTHRAX (Bacillus anthracis)
  3. 2.3AVIAN INFLUENZA A/H5 OR A/H5N1 IN HUMANS
  4. 2.4BOTULISM (Clostridium botulinum)
  5. 2.5BRUCELLOSIS (Brucella spp.)
  6. 2.6CAMPYLOBACTERIOSIS (Campylobacter spp.)
  7. 2.7CHLAMYDIAL INFECTION (Chlamydia trachomatis), INCLUDING LYMPHOGRANULOMA VENEREUM (LGV)
  8. 2.8CHOLERA (Vibrio cholerae)
  9. 2.9CREUTZFELDT-JAKOB DISEASE, VARIANT (vCJD)
  10. 2.10CRYPTOSPORIDIOSIS (Cryptosporidium spp.)
  11. 2.11DIPHTHERIA (Corynebacterium diphtheriae, Corynebacterium ulcerans and Corynebacterium pseudotuberculosis)
  12. 2.12ECHINOCOCCOSIS (Echinococcus spp.)
  13. 2.13GIARDIASIS (Giardia lamblia)
  14. 2.14GONORRHOEA (Neisseria gonorrhoeae)
  15. 2.15HAEMOPHILUS INFLUENZAE, INVASIVE DISEASE (Haemophilus influenzae)
  16. 2.16HEPATITIS A (Hepatitis A virus)
  17. 2.17HEPATITIS B (Hepatitis B virus)
  18. 2.18HEPATITIS C (Hepatitis C virus)
  19. 2.19INFLUENZA (Influenza virus)
  20. 2.20INFLUENZA A(H1N1)
  21. 2.21LEGIONNAIRES’ DISEASE (Legionella spp.)
  22. 2.22LEPTOSPIROSIS (Leptospira spp.)
  23. 2.23LISTERIOSIS (Listeria monocytogenes)
  24. 2.24MALARIA (Plasmodium spp.)
  25. 2.25MEASLES (Measles virus)
  26. 2.26MENINGOCCOCAL DISEASE, INVASIVE (Neisseria meningitidis)
  27. 2.27MUMPS (Mumps virus)
  28. 2.28PERTUSSIS (Bordetella pertussis)
  29. 2.29PLAGUE (Yersinia pestis)
  30. 2.30PNEUMOCOCCAL INVASIVE DISEASE(S) (Streptococcus pneumoniae)
  31. 2.31POLIOMYELITIS (Polio virus)
  32. 2.32Q FEVER (Coxiella burnetii)
  33. 2.33RABIES (Lyssa virus)
  34. 2.34RUBELLA (Rubella virus)
  35. 2.35RUBELLA, CONGENITAL (Including Congenital Rubella Syndrome)
  36. 2.36SALMONELLOSIS (Salmonella spp. other than Salmonella typhi and Salmonella paratyphi)
  37. 2.37SEVERE ACUTE RESPIRATORY SYNDROME — SARS (SARS-coronavirus, SARS-CoV)
  38. 2.38SHIGA TOXIN/VEROCYTO-TOXIN PRODUCING ESCHERICHIA COLI INFECTION (STEC/VTEC)
  39. 2.39SHIGELLOSIS (Shigella spp.)
  40. 2.40SMALLPOX (Variola virus)
  41. 2.41SYPHILIS (Treponema pallidum)
  42. 2.42SYPHILIS, CONGENITAL AND NEONATAL (Treponema pallidum)
  43. 2.43TETANUS (Clostridium tetani)
  44. 2.44TICK-BORNE ENCEPHALITIS (TBE virus)
  45. 2.45TOXOPLASMOSIS, CONGENITAL (Toxoplasma gondii)
  46. 2.46TRICHINELLOSIS (Trichinella spp.)
  47. 2.47TUBERCULOSIS (Mycobacterium tuberculosis complex)
  48. 2.48TULARAEMIA (Francisella tularensis)
  49. 2.49TYPHOID/PARATYPHOID FEVER (Salmonella typhi/paratyphi)
  50. 2.50VIRAL HAEMORRHAGIC FEVERS (VHF)
  51. 2.51WEST NILE FEVER (West Nile virus infection, WNV)
  52. 2.52YELLOW FEVER (Yellow fever virus)
  53. 2.53YERSINIOSIS (Yersinia enterocolitica, Yersinia pseudotuberculosis)

Annotations

Textual amendments

F1

Repealed by Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance).